Recent Years Saw Increase in U.S. Pregnancy-Related Deaths
By Elana Gotkine HealthDay Reporter
FRIDAY, April 18, 2025 -- During 2018 to 2022, pregnancy-related deaths in the United States increased, according to a study published online April 9 in JAMA Network Open.
Yingxi Chen, M.D., Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues examined the age-standardized national rates of pregnancy-related death from 2018 to 2022 in the United States using data from the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research.
There were 6,283 pregnancy-related deaths, including 1,891 late maternal deaths during 2018 to 2022. The researchers found that there was an increase in the age-standardized annual and aggregated rate of pregnancy-related mortality (ASR) by 27.7 percent from 2018 to 2022 (25.3 to 32.6 deaths per 100,000 live births). The increase was seen across age groups and was disproportionately driven by deaths among women aged 25 to 39 years (by 36.8 percent). Considerable variation was seen in rates by state, from 18.5 to 59.7 deaths per 100,000 live births. Overall, 2,679 pregnancy-related deaths could have been prevented from 2018 to 2022 if the national rate was reduced to the lowest state rate. The highest ASR was seen in American Indian and Alaska Native women, followed by non-Hispanic Black women (106.3 and 76.9 deaths per 100,000 live births, respectively). Mental and behavior disorders and drug-induced and alcohol-induced death were important contributing causes of late maternal death, although cardiovascular disease was the leading cause of the overall pregnancy-related deaths.
"Our analysis provides important insights that should inform the shared goal of preventing avoidable pregnancy-related deaths in the United States," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 -- Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do...
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
TUESDAY, May 20, 2025 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published...
AAP Updates Guidance on Evaluation, Treatment of Patent Ductus Arteriosus in Preemies
THURSDAY, May 15, 2025 -- In a clinical report published in the May issue of Pediatrics, the American Academy of Pediatrics presents updated guidance on the evaluation and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.